Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1994 May;49(5):485–491. doi: 10.1136/thx.49.5.485

Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma.

K Rajakulasingam 1, R Polosa 1, M K Church 1, P H Howarth 1, S T Holgate 1
PMCID: PMC474871  PMID: 8016771

Abstract

BACKGROUND--Inhaled frusemide exerts a protective effect against bronchoconstriction induced by several indirect stimuli in asthma. This effect could be caused by interference with neural pathways. The effect of inhaled frusemide on bronchoconstriction induced by inhaled bradykinin, which is thought to cause bronchoconstriction via neural mechanisms, was studied and compared with the effects of adenosine 5'-monophosphate (AMP) which probably produces its airway effects by augmenting mast cell mediator release and interfering with neural pathways. METHODS--Patients first underwent AMP and bradykinin challenges. They were then studied in a randomised, placebo controlled, double blind fashion. Ten atopic asthmatic subjects, studied on four days, were pretreated with inhaled frusemide (40 mg) or placebo for 10 minutes, five minutes before challenge with increasing concentrations of nebulised AMP or bradykinin. RESULTS--On the open visit days the provocative concentrations required to reduce forced expiratory volume in one second (FEV1) by 20% from baseline (PC20) for AMP and bradykinin were 16.23 (1.42-67.16) and 2.75 (0.81-6.6) mg/ml. There was a significant correlation between baseline AMP and bradykinin PC20 values. For AMP the geometric mean PC20 values following pretreatment with inhaled frusemide and matched placebo were 80.97 (9.97- > 400.0) and 14.86 (2.6-104.6) mg/ml respectively (95% CI 0.49 to 0.98). For bradykinin the geometric mean PC20 values following pretreatment with inhaled frusemide and matched placebo were 13.22 (2.53- > 16.0) and 2.52 (0.45-5.61) mg/ml respectively (95% CI 0.43 to 1.01). Frusemide afforded 5.45 and 5.24 fold protection against AMP and bradykinin-induced bronchoconstriction respectively. Furthermore, there was a significant correlation between protection afforded to the airways against AMP and bradykinin. CONCLUSIONS--These data suggest that inhaled frusemide affords protection against bradykinin-induced bronchoconstriction which is comparable to that against AMP, supporting a common mechanism of action for frusemide.

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. D., He W., Temple D. M. Inhibition by furosemide of inflammatory mediators from lung fragments. N Engl J Med. 1991 Jan 10;324(2):131–131. doi: 10.1056/NEJM199101103240218. [DOI] [PubMed] [Google Scholar]
  2. Beasley R., Varley J., Robinson C., Holgate S. T. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma. Am Rev Respir Dis. 1987 Nov;136(5):1140–1144. doi: 10.1164/ajrccm/136.5.1140. [DOI] [PubMed] [Google Scholar]
  3. Bianco S., Pieroni M. G., Refini R. M., Rottoli L., Sestini P. Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions. N Engl J Med. 1989 Oct 19;321(16):1069–1073. doi: 10.1056/NEJM198910193211602. [DOI] [PubMed] [Google Scholar]
  4. Bianco S., Robuschi M., Ceserani R., Gandolfi C. Effects of prostacyclin on aspecifically and specifically induced bronchoconstriction in asthmatic patients. Eur J Respir Dis Suppl. 1980;106:81–87. [PubMed] [Google Scholar]
  5. Bianco S., Vaghi A., Robuschi M., Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet. 1988 Jul 30;2(8605):252–255. doi: 10.1016/s0140-6736(88)92540-8. [DOI] [PubMed] [Google Scholar]
  6. Bourland W. A., Day D. K., Williamson H. E. The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. J Pharmacol Exp Ther. 1977 Jul;202(1):221–229. [PubMed] [Google Scholar]
  7. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  8. Crimi N., Palermo F., Polosa R., Oliveri R., Maccarrone C., Palermo B., Mistretta A. Effect of indomethacin on adenosine-induced bronchoconstriction. J Allergy Clin Immunol. 1989 May;83(5):921–925. doi: 10.1016/0091-6749(89)90106-1. [DOI] [PubMed] [Google Scholar]
  9. Dixon C. M., Barnes P. J. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol. 1989 Jun;27(6):831–836. doi: 10.1111/j.1365-2125.1989.tb03446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Elwood W., Lötvall J. O., Barnes P. J., Chung K. F. Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways. Am Rev Respir Dis. 1991 Jun;143(6):1340–1344. doi: 10.1164/ajrccm/143.6.1340. [DOI] [PubMed] [Google Scholar]
  11. Fuller R. W., Dixon C. M., Cuss F. M., Barnes P. J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis. 1987 Jan;135(1):176–180. doi: 10.1164/arrd.1987.135.1.176. [DOI] [PubMed] [Google Scholar]
  12. Grubbe R. E., Hopp R., Dave N. K., Brennan B., Bewtra A., Townley R. Effect of inhaled furosemide on the bronchial response to methacholine and cold-air hyperventilation challenges. J Allergy Clin Immunol. 1990 May;85(5):881–884. doi: 10.1016/0091-6749(90)90072-c. [DOI] [PubMed] [Google Scholar]
  13. Hardy C. C., Bradding P., Robinson C., Holgate S. T. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol (1985) 1988 Apr;64(4):1567–1574. doi: 10.1152/jappl.1988.64.4.1567. [DOI] [PubMed] [Google Scholar]
  14. Holtzman M. J., Sheller J. R., Dimeo M., Nadel J. A., Boushey H. A. Effect of ganglionic blockade on bronchial reactivity in atopic subjects. Am Rev Respir Dis. 1980 Jul;122(1):17–25. doi: 10.1164/arrd.1980.122.1.17. [DOI] [PubMed] [Google Scholar]
  15. Ichinose M., Belvisi M. G., Barnes P. J. Bradykinin-induced bronchoconstriction in guinea pig in vivo: role of neural mechanisms. J Pharmacol Exp Ther. 1990 May;253(2):594–599. [PubMed] [Google Scholar]
  16. Ichinose M., Nakajima N., Takahashi T., Yamauchi H., Inoue H., Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet. 1992 Nov 21;340(8830):1248–1251. doi: 10.1016/0140-6736(92)92948-f. [DOI] [PubMed] [Google Scholar]
  17. Mann J. S., Cushley M. J., Holgate S. T. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition. Am Rev Respir Dis. 1985 Jul;132(1):1–6. doi: 10.1164/arrd.1985.132.1.1. [DOI] [PubMed] [Google Scholar]
  18. Newman S. P., Pellow P. G., Clarke S. W. Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas. 1986 May;7(2):139–146. doi: 10.1088/0143-0815/7/2/004. [DOI] [PubMed] [Google Scholar]
  19. Nichol G. M., Alton E. W., Nix A., Geddes D. M., Chung K. F., Barnes P. J. Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis. 1990 Sep;142(3):576–580. doi: 10.1164/ajrccm/142.3.576. [DOI] [PubMed] [Google Scholar]
  20. O'Connor B. J., Chung K. F., Chen-Worsdell Y. M., Fuller R. W., Barnes P. J. Effect of inhaled furosemide and bumetanide on adenosine 5'-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis. 1991 Jun;143(6):1329–1333. doi: 10.1164/ajrccm/143.6.1329. [DOI] [PubMed] [Google Scholar]
  21. Pauwels R. A., Van der Straeten M. E. An animal model for adenosine-induced bronchoconstriction. Am Rev Respir Dis. 1987 Aug;136(2):374–378. doi: 10.1164/ajrccm/136.2.374. [DOI] [PubMed] [Google Scholar]
  22. Pavord I. D., Wisniewski A., Mathur R., Wahedna I., Knox A. J., Tattersfield A. E. Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax. 1991 Sep;46(9):633–637. doi: 10.1136/thx.46.9.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pavord I. D., Wisniewski A., Tattersfield A. E. Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax. 1992 Oct;47(10):797–800. doi: 10.1136/thx.47.10.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peachell P. T., Columbo M., Kagey-Sobotka A., Lichtenstein L. M., Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis. 1988 Nov;138(5):1143–1151. doi: 10.1164/ajrccm/138.5.1143. [DOI] [PubMed] [Google Scholar]
  25. Phillips G. D., Holgate S. T. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma. Am Rev Respir Dis. 1989 Feb;139(2):463–469. doi: 10.1164/ajrccm/139.2.463. [DOI] [PubMed] [Google Scholar]
  26. Phillips G. D., Rafferty P., Beasley R., Holgate S. T. Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma. Thorax. 1987 Dec;42(12):939–945. doi: 10.1136/thx.42.12.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Phillips G. D., Scott V. L., Richards R., Holgate S. T. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5'-monophosphate. Eur Respir J. 1989 Mar;2(3):210–217. [PubMed] [Google Scholar]
  28. Polosa R., Holgate S. T. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1367–1371. doi: 10.1164/ajrccm/142.6_Pt_1.1367. [DOI] [PubMed] [Google Scholar]
  29. Polosa R., Lau L. C., Holgate S. T. Inhibition of adenosine 5'-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J. 1990 Jun;3(6):665–672. [PubMed] [Google Scholar]
  30. Polosa R., Phillips G. D., Lai C. K., Holgate S. T. Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma. Allergy. 1990 Apr;45(3):174–182. doi: 10.1111/j.1398-9995.1990.tb00480.x. [DOI] [PubMed] [Google Scholar]
  31. Polosa R., Phillips G. D., Rajakulasingam K., Holgate S. T. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma. J Allergy Clin Immunol. 1991 May;87(5):939–947. doi: 10.1016/0091-6749(91)90415-k. [DOI] [PubMed] [Google Scholar]
  32. Rajakulasingam K., Polosa R., Church M. K., Holgate S. T., Howarth P. H. Kinins and rhinitis. Clin Exp Allergy. 1992 Aug;22(8):734–740. doi: 10.1111/j.1365-2222.1992.tb02812.x. [DOI] [PubMed] [Google Scholar]
  33. Robuschi M., Gambaro G., Spagnotto S., Vaghi A., Bianco S. Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulm Pharmacol. 1989;1(4):187–191. doi: 10.1016/s0952-0600(89)80016-x. [DOI] [PubMed] [Google Scholar]
  34. Scherer B., Weber P. C. Time-dependent changes in prostaglandin excretion in response to frusemide in man. Clin Sci (Lond) 1979 Jan;56(1):77–81. doi: 10.1042/cs0560077. [DOI] [PubMed] [Google Scholar]
  35. Schulman E. S., Adkinson N. F., Jr, Newball H. H. Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):589–595. doi: 10.1152/jappl.1982.53.3.589. [DOI] [PubMed] [Google Scholar]
  36. Struyker-Boudier H. A., Smits J. F., Kleinjans J. C., van Essen H. Hemodynamic actions of diuretic agents. Clin Exp Hypertens A. 1983;5(2):209–223. doi: 10.3109/10641968309048822. [DOI] [PubMed] [Google Scholar]
  37. Szczeklik A., Gryglewski R. J., Nizankowski R., Musiał J., Pietoń R., Mruk J. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun. 1978 Jun;10(6):545–556. doi: 10.1016/s0031-6989(78)80053-8. [DOI] [PubMed] [Google Scholar]
  38. Ventresca P. G., Nichol G. M., Barnes P. J., Chung K. F. Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am Rev Respir Dis. 1990 Jul;142(1):143–146. doi: 10.1164/ajrccm/142.1.143. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES